<i>Staphylococcus aureus</i>Capsular Polysaccharides

10.1128/iai.59.3.1008-1014.1991

10.1128/jcm.26.12.2505-2509.1988

Arbeit, R. D., and R. M. Dunn. 1987. Expression of capsular polysaccharide during experimental focal infection with Staphylococcus aureus.J. Infect. Dis.156:947-952.

10.1016/0732-8893(84)90002-6

Arbeit, R. D., and M. J. Nelles. 1987. Capsular polysaccharide antigenemia in rats with experimental endocarditis due to Staphylococcus aureus.J. Infect. Dis.155:242-246.

10.1128/jb.173.14.4333-4340.1991

10.1093/infdis/165.4.749

Reference deleted.

10.1046/j.1365-2958.1998.00646.x

10.1128/IAI.68.2.931-936.2000

10.3201/eid0702.010204

Christensson, B., A. Boutonnier, U. Ryding, and J. M. Fournier. 1991. Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureuscapsular polysaccharide type 5 and 8. J. Infect. Dis.163:530-533.

Cohn, Z. 1962. Determinants of infection in the peritoneal cavity. 1. Response to and fate of Staphyococcus aureus and Staphylococcus albus in the mouse. Yale J. Biol. Med.35:12-28.

10.1046/j.1365-2958.2001.02589.x

10.1128/IAI.69.11.6796-6803.2001

10.1128/IAI.71.2.656-662.2003

10.1128/iai.64.7.2408-2414.1996

10.1099/00221287-139-6-1301

10.1099/00221287-137-5-1155

Daum, R. S., A. Fattom, S. Freese, and W. Karakawa. 1994. Capsular polysaccharide serotypes of coagulase-positive staphylococci associated with tenosynovitis, osteomyelitis, and other invasive infections in chickens and turkeys: evidence for new capsular types. Avian Dis.38:762-771.

Donnelly, T. M., and D. M. Stark. 1985. Susceptibility of laboratory rats, hamsters, and mice to wound infection with Staphylococcus aureus.Am. J. Vet. Res.46:2634-2638.

10.1086/342576

Ekstedt, R. 1963. Studies on immunity to staphylococcal infection in mice. I. Effect of dosage, viability, and interval between immunization and challenge on resistance to infection following injection of whole cell vaccines. J. Infect. Dis.112:143-151.

Ekstedt, R. 1966. Studies on immunity to staphylococcal infection in mice. intravenously. The role of specific and nonspecific immunity. J. Infect. Dis.116:514-522.

Ekstedt, R. D. 1963. Studies on immunity to staphylococcal infection in mice. II. Effect of immunization with fractions of Staphylococcus aureus prepared by physical and chemical methods. J. Infect. Dis.112:152-157.

Fattom, A., X. Li, Y. H. Cho, A. Burns, A. Hawwari, S. E. Shepherd, R. Coughlin, S. Winston, and R. Naso. 1995. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine13:1288-1293.

10.1128/iai.61.3.1023-1032.1993

10.1128/iai.58.7.2367-2374.1990

10.1128/iai.64.5.1659-1665.1996

Fisher, M., H. Devlin, and A. Erlandson. 1963. A new staphylococcal antigen. Its preparation and immunizing activity against experimental infections. Nature199:1074-1075.

Fisher, S. 1960. A heat stable protective staphylococcal antigen. Aust. J. Exp. Biol.38:479-486.

Fournier, J. M., K. Hannon, M. Moreau, W. W. Karakawa, and W. F. Vann. 1987. Isolation of type 5 capsular polysaccharide from Staphylococcus aureus.Ann. Inst. Pasteur Microbiol.138:561-567.

10.1128/iai.45.1.87-93.1984

10.1128/IAI.66.8.4004-4007.1998

10.1086/520463

10.1128/iai.61.2.478-485.1993

10.1016/0264-410X(94)90103-1

10.1128/jb.21.3.157-160.1931

10.1016/S0140-6736(02)07877-7

10.1086/520437

Gorrill, R. H. 1958. The establishment of staphylococcal abscesses in the mouse kidney. Br. J. Exp. Pathol.39:203-212.

10.1128/iai.55.12.3030-3034.1987

10.1016/S0378-1135(97)00172-7

Hanessian, S., and T. Haskell. 1964. Structural studies on staphylococcal polysaccharide antigen. J. Biol. Chem.239:2758-2764.

10.3168/jds.S0022-0302(00)75073-9

Herbelin, C., and B. Poutrel. 1996. Immunogenicity in mice of multivalent conjugates composed of Staphylococcus aureus type 5 and 8 capsular polysaccharides and α- and β-toxins. Vaccine Res.5:15-28.

10.1128/JB.183.15.4609-4613.2001

10.1086/514061

10.1128/jcm.25.3.526-530.1987

10.1097/00006454-200012000-00009

10.1128/iai.56.5.1090-1095.1988

Karakawa, W. W., and W. F. Vann. 1982. Capsular polysaccharides of Staphylococcus aureus.Semin. Infect. Dis.4:285-293.

10.1128/JB.181.16.4818-4824.1999

10.1128/IAI.67.10.5001-5006.1999

10.1074/jbc.M203867200

Koenig, M. G. 1962. Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants. Yale J. Biol. Med.34:537-559.

10.1128/iai.57.8.2306-2312.1989

10.1016/0378-1119(95)00684-2

Lee C. Y. 2001. Capsule production p. 49-66. In A. L. Honeyman H. Friedman and M. Bendinelli (ed.) Staphylococcus aureus infection and disease. Kluwer Academic/Plenum Publishers New York N.Y.

10.1111/j.1365-2958.1992.tb00872.x

Lee J. C. 2001. Capsule and vaccine development p. 39-47. In A. L. Honeyman H. Friedman and M. Bendinelli (ed.) Staphylococcus aureus infection and disease. Kluwer Academic/Plenum Publishers New York N.Y.

10.1093/infdis/156.5.741

Lee J. C. and C. Y. Lee. 1999. Capsular polysaccharides of Staphylococcus aureus p. 185-205. In J. B. Goldberg (ed.) Genetics of bacterial polysaccharides. CRC Press Boca Raton Fla.

10.1128/jcm.28.12.2612-2615.1990

10.1128/iai.55.9.2191-2197.1987

10.1128/iai.65.10.4146-4151.1997

10.1093/infdis/157.4.723

10.1128/iai.61.5.1853-1858.1993

10.1128/iai.33.3.714-724.1981

10.1128/jb.131.1.194-200.1977

10.1128/jb.176.22.7005-7016.1994

10.1128/IAI.70.2.444-450.2002

10.1128/IAI.70.7.3389-3395.2002

10.1128/JB.184.13.3623-3629.2002

Luong T. T. S. W. Newell and C. Y. Lee. 2003. mgr a novel global regulator in Staphylococcus aureus . J. Bacteriol. 185: 3703-3710.

10.1126/science.284.5419.1523

10.1128/iai.10.2.389-397.1974

Moran, G. J., and J. Mount. 2003. Staphylococcus aureus resistant to vancomycin—United States, 2002. Ann. Emerg. Med.41:148-151.

10.1016/0008-6215(90)84244-O

10.1128/iai.63.12.4738-4743.1995

10.1016/0008-6215(83)88080-X

Naso R. and A. Fattom. 1996. Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections p. 133-140. In S. Cohen and A. Shafferman (ed.) Novel strategies in design and production of vaccines. Plenum Press New York N.Y.

10.1128/iai.63.2.375-380.1995

10.1128/iai.65.10.4216-4221.1997

Ohtomo, T., and K. Yoshida. 1978. Encapsulation by transformation of strains of Staphylococcus aureus determined by the serum-soft agar technique. Zentralbl. Bakteriol. Hyg. Abt. Orig. A242:436-445.

10.1046/j.1365-2958.1997.d01-1865.x

10.1128/JB.181.8.2492-2500.1999

10.1128/iai.19.3.943-949.1978

10.1128/IAI.68.9.4865-4871.2000

10.1128/IAI.69.2.917-923.2001

10.1128/cdli.2.2.166-171.1995

10.1128/cdli.4.3.275-278.1997

10.1128/jcm.31.2.467-469.1993

Projan S. J. and R. P. Novick. 1997. The molecular basis of pathogenicity p. 55-81. In K. B. Crossley and G. L. Archer (ed.) The staphyloccci in human disease. Churchill Livingstone New York N.Y.

Reynaud-Rondier, L., A. Voiland, and G. Michel. 1991. Conjugation of capsular polysaccharide to α-hemolysin from Staphylococcus aureus as a glycoprotein antigen. FEMS Microbiol. Lett.76:193-200.

Robbins J. B. S. R. W. B. Egan W. Vann and D. Liu. 1980. Virulence properties of bacterial capsular polysaccharides-unanswered questions p. 115-132. In H. Smith J. Skehel and M. Turner (ed.) The molecular basis of microbial pathogenicity. Verlag Chemie GmbH Weinheim Germany.

10.1099/00221287-143-7-2395

10.1128/jb.179.5.1614-1621.1997

10.1099/00222615-2-3-253

10.1056/NEJMoa011297

Singh, G., R. R. Marples, and A. M. Kligman. 1971. Experimental Staphylococcus aureus infections in humans. J. Investig. Dermatol.57:149-162.

Smith, I. M., A. P. Wilson, E. Hazard, H. W. K., and M. E. Dewey. 1960. Death from staphylococci in mice. J. Infect. Dis.107:369-378.

10.1128/iai.17.1.231-234.1977

10.1128/jcm.22.5.828-834.1985

10.1128/JCM.38.2.846-850.2000

10.1093/infdis/167.2.475

10.1128/iai.59.4.1325-1333.1991

10.1128/aem.57.2.618-621.1991

10.1128/jcm.28.10.2253-2258.1990

10.1128/IAI.66.11.5183-5189.1998

10.1128/JCM.38.8.2998-3003.2000

10.1016/S0264-410X(01)00124-4

10.1073/pnas.161175598

Vann W. F. M. Moreau A. Sutton R. A. Byrd and W. W. Karakawa. 1988. Structure and immunochemistry of Staphylococcus aureus capsular polysaccharides p. 187-198. In M. A. Horwitz (ed.) Bacterial-host cell interaction vol. 64. UCLA Symposia on Molecular and Cellular Biology. Alan R. Liss Inc. New York N.Y.

10.1006/mpat.2002.0513

10.1093/infdis/144.1.1

Verbrugh, H. A., P. K. Peterson, B. Y. Nguyen, S. P. Sisson, and Y. Kim. 1982. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J. Immunol.129:1681-1687.

Verhoef, J., P. Peterson, Y. Kim, L. D. Sabath, and P. G. Quie. 1977. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology33:191-197.

10.1111/j.1574-6968.1999.tb13360.x

Welch, P. G., A. Fattom, J. Moore, R. Schneerson, J. Shiloach, D. A. Bryla, X. R. Li, and J. B. Robbins. 1996. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J. Am. Soc. Nephrol.7:247-253.

10.1128/jcm.27.6.1286-1291.1989

10.1111/j.1749-6632.1974.tb41493.x

Wilkinson B. J. 1983. Staphylococcal capsules and slime p. 481-523. In C. Easmon and C. Adlam (ed.) Staphylococci and staphylococcal infections vol. 2. Academic Press London England.

10.1128/jb.108.2.874-884.1971

10.1128/iai.60.4.1358-1362.1992